Can-Fite will participate in a prominent industry event, the BIO CEO & Investor Conference, which provides a platform for visibility and networking with investors and potential partners.

The patent covers the oral administration of the drug to treat obesity. Credit: Cynthia A Jackson/Shutterstock. Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for ...

27, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological ...

Carol Fite, of the Tallahassee area, formerly of Bainbridge, GA, passed away on Friday, January 18, 2025, at 69 years of age. Born in Albany, GA on November 4, 1955, she was the daughter of the ...